Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
RNXT

RenovoRx (RNXT) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $1.28 -3.8% on the day +14.3% over 12 months 52-week range $0.73 – $2.52

Share price and insider trades

RNXT closeInsider buyInsider sale
0123NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $0 on 2026-03-20 · Laurence Marton, Mark Voll, Shaun BagaiBought $170 on 2025-12-30 · Ramtin AgahBought $4,250 on 2025-12-17 · Shaun BagaiBought $4,500 on 2025-12-18 · Shaun BagaiBought $8,000 on 2025-11-21 · Ramtin AgahBought $8,424 on 2025-12-31 · Ramtin AgahBought $9,600 on 2025-12-05 · Ramtin AgahBought $9,600 on 2025-11-24 · Ramtin AgahBought $10,000 on 2026-01-21 · Ramtin AgahBought $10,200 on 2025-12-16 · Ramtin AgahBought $19,750 on 2026-05-19 · Mark Voll
Bought, 12 months$40K
Sold, 12 months$0
Insiders buying2
Insiders selling0

RenovoRx insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $40K and 0 sold $0 of RNXT stock on the open market.

RNXT insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $55K bought (8 trades)$55KQ4 2025Q1 2026: $10K bought (1 trades)$10KQ1 2026Q2 2026: $20K bought (1 trades)$20KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$20K1—0
Q1 2026$10K1—0
Q4 2025$55K8—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit+$42KOn all tracked purchases +50.0%

Summary

Over the past 12 months, 2 RenovoRx, Inc. insiders reported open-market purchases totaling $40K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Ramtin Agah (Chief Medical Officer) has the highest Insider Score at 50.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
May 21SEC Mark VollCFO Buy 25,000142,380 held (+21%) $0.79 $20K +62.0% —
Mar 24SEC Shaun BagaiCEO Buy 24,300313,357 held (+8%) — $0 — —
Mar 24SEC Mark VollCFO Buy 97,200new position — $0 — —
Mar 24SEC Laurence MartonDirector Buy 9,720new position — $0 — —
Jan 22SEC Ramtin AgahChief Medical Officer Buy 10,000798,460 held (+1%) $1.00 $10K +28.0% 50
Jan 5SEC Ramtin AgahChief Medical Officer Buy 9,795788,460 held (+1%) $0.86 $8K +48.8% 50
Jan 2SEC Ramtin AgahChief Medical Officer Buy 205778,665 held (+0%) $0.83 $170 +54.2% 50
Dec 22SEC Shaun BagaiCEO Buy 5,000340,040 held (+1%) $0.90 $4K +42.2% —
Dec 19SEC Shaun BagaiCEO Buy 5,000335,040 held (+2%) $0.85 $4K +50.6% —
Dec 17SEC Ramtin AgahChief Medical Officer Buy 12,000778,460 held (+2%) $0.85 $10K +50.6% 50
Dec 8SEC Ramtin AgahChief Medical Officer Buy 10,000766,460 held (+1%) $0.96 $10K +33.3% 50
Nov 24SEC Ramtin AgahChief Medical Officer Buy 12,000756,460 held (+2%) $0.80 $10K +60.0% 50
Nov 24SEC Ramtin AgahChief Medical Officer Buy 10,000744,460 held (+1%) $0.80 $8K +60.0% 50

Insiders at RenovoRx, Inc.

InsiderBoughtSoldLast filingScore
Ramtin AgahChief Medical Officer $56K — Jan 22, 2026 50
Mark VollCFO $20K — May 21, 2026 —
Shaun BagaiCEO $9K — Mar 24, 2026 —
Laurence MartonDirector — — Mar 24, 2026 —

RNXT stock: common questions

Are RenovoRx, Inc. insiders buying RNXT stock?

In the past 12 months, 2 insiders reported open-market purchases of RNXT worth $40K. The latest was CFO Mark Voll bought $20K of RNXT at $0.79 — first open-market purchase in our records; raises the stake by 21%.

Are RenovoRx, Inc. insiders selling RNXT stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is RNXT's 52-week range?

Over the past year RNXT has traded between $0.73 and $2.52. It last closed at $1.28 on Oct 9, 2026.